A novel small molecule inhibitor of CD73 triggers immune-mediated multiple myeloma cell death
Highlights CD73 is the key ectoenzyme involved in the generation of AMP-derived adenosine, which contributes to immunosuppression in the MM BM milieu. Blocking CD73 activity with a potent, selective, orally bioavailable CD73 inhibitor ORIC-533 decreases adenosine generation, overcomes immune suppres...
| 出版年: | Blood Cancer Journal |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , , , , , , |
| フォーマット: | 論文 |
| 言語: | 英語 |
| 出版事項: |
Nature Publishing Group
2024-04-01
|
| オンライン・アクセス: | https://doi.org/10.1038/s41408-024-01019-5 |
